课题基金 / 基金详情

Resetting epithelial differentiation as a novel therapeutic approach to treating asthma

Resetting epithelial differentiation as a novel therapeutic approach to treating asthma
重置上皮分化作为治疗哮喘的新方法
批准号:
239919
负责人:
Knight Darryl A
金额:
$48.87万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2016-09-01

项目摘要

项目成果

Knight Darryl A的其他基金

相似基金

相关文献

中文摘要
翻译
虽然过敏很常见,影响到大多数西方国家约40%的人口,但只有一部分过敏人群会患上哮喘。这突出了导致疾病的组织和细胞特异性机制的重要性。在
英文摘要
While allergies are very common, affecting ~40% of the population in most Western countries, only a proportion of allergic people develop asthma. This highlights the importance of tissue and cell specific mechanisms that contribute to the disease. In the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhaled Corticosteroids as risk factors for severe viral infections in asthmatics: lessons from the H1N1 epidemic
  • 批准号:
    239926
  • 项目类别:
    Operating Grants
  • 资助金额:
    $36.48万
  • 财政年份:
    2011
  • 负责人:
    Knight Darryl A
  • 依托单位:
Heart and Lung Health FEST 2011
  • 批准号:
    217583
  • 项目类别:
    Miscellaneous Programs
  • 资助金额:
    $0.55万
  • 财政年份:
    2010
  • 负责人:
    Knight Darryl A
  • 依托单位:
Dysregulated STAT-3 activation underlies lung fibroblast heterogeneity: Implications for idiopathic pulmonary fibrosis
  • 批准号:
    181521
  • 项目类别:
    Operating Grants
  • 资助金额:
    $48.43万
  • 财政年份:
    2009
  • 负责人:
    Knight Darryl A
  • 依托单位:
海外基金